US-based Waters Corporation has launched Waters AI Link, a software capability that brings Anthropic's Model Context Pro...
Theramex, a London-headquartered specialty pharmaceutical company dedicated to women and their health, and China-based A...
Chinese startup Rona Therapeutics has granted Roche an exclusive worldwide license for Rona's investigational RNAi candi...
South Korea-based NTL HEALTHCARE, a women's health AI company, has announced the global launch of CerviCARE® AI AT, ...
Americhem, a global leader in custom polymer solutions, recently celebrated the opening of its new clean compounding fac...
ITOCHU Corporation has signed a capital alliance agreement with MOLCURE Inc., which possesses AI-driven drug discovery t...
Australia-based Firebrick Pharma has secured firm commitments from strategic investors for approximately $732k, through ...
Japan-based Ono Pharmaceutical has entered into an exclusive license agreement with Biohaven, together with its wholly o...
South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced a strateg...
Taiwan-based Foresee Pharmaceuticals has been notified by its licensing partner, Changchun GeneScience Pharmaceutical (G...
Japan-based Shimadzu Corporation has started the development and validation of a mass spectrometry (MS) solution for cor...
US-based Danaher Corporation has announced plans to launch its first AI-powered autonomous lab, designed to help researc...
South Korea-based LOTTE Biologics, a contract development and manufacturing (CDMO) organisation, and Alvotech, a global ...
GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopha...
If the opening day of BioJapan 2026 diagnosed the gap between Japanese science and global deals, the second day at PACIF...
China's XtalPi Holdings, an AI and robotics-driven drug and materials discovery company, has debuted Kodexia™, the...
South Korea-based GC Cell, a leader in the cell and gene therapy (CGT) sector within the biopharmaceutical industry, and...
Japan-based Shionogi & Co. is entering into an agreement to acquire IntraBio Inc, a biopharmaceutical company develo...
AstraZeneca has announced the opening of its newest global strategic research and development (R&D) centre, in Kenda...
Yokohama, 7 October 2026 | BioJapan 2026, Regenerative Medicine JAPAN and healthTECH JAPAN, PACIFICO Yokoham...
Merck, known as MSD outside of the United States and Canada, and China-based startup SciBrunch Therapeutics have entered...
China-based startup Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, has entered...
Taiwan-based Energenesis Biomedical has signed a Memorandum of Understanding (MoU) with Yoo Young Pharm (YYO), a South K...
SK pharmteco, a subsidiary of SK Inc., the strategic investment company for SK Group, South Korea’s second-la...
Qiagen has announced new artificial intelligence (AI) capabilities to help researchers analyse complex biological and ge...
